Workflow
Moderna Stock Heads for Worst-Ever Day After Reducing Revenue Forecast
MRNAModerna(MRNA) Schaeffers Investment Research·2025-01-13 15:34

Moderna Inc (NASDAQ:MRNA) lowered its 2025 revenue forecast to a range of 1.5billionto1.5 billion to 2.5 billion, marking a 1billionreductionfrompreviousestimates.TheadjustmentreflectsweakerdemandforitsCovid−19andRSVvaccines,withthecompanyprojectingthatmostoftherevenuewillmaterializeinthesecondhalfoftheyear.Inresponse,MRNAwaslastseen241 billion reduction from previous estimates. The adjustment reflects weaker demand for its Covid-19 and RSV vaccines, with the company projecting that most of the revenue will materialize in the second half of the year.In response, MRNA was last seen 24% lower to trade at 32.11, at its lowest level since April 2020 -- before its pandemic-era surge -- and heading for its worst-ever single-day s ...